Biological Implications and Functional Significance of Transglutaminase Type 2 in Nervous System Tumors
Authors:
- Mariachiara BuccarelliMBMariachiara Buccarelli
- Giorgia CastellaniGCGiorgia Castellani
- Vincenzo FiorentinoVincenzo Fiorentino
- Cristina PizzimentiCPCristina Pizzimenti
- Simone BeninatiSimone Beninati
- Lucia Ricci-VitianiLRLucia Ricci-Vitiani
- Maria Luisa ScattoniMSMaria Luisa Scattoni
- Carlo MischiatiCarlo Mischiati
- Francesco FacchianoFFFrancesco Facchiano
- Claudio TabolacciCTClaudio Tabolacci
Open Access
Abstract
Transglutaminase type 2 (TG2) is the most ubiquitously expressed member of the transglutaminase family. TG2 catalyzes the transamidation reaction leading to several protein post-translational modifications and it is also implicated in signal transduction thanks to its GTP binding/hydrolyzing activity. In the nervous system, TG2 regulates multiple physiological processes, such as development, neuronal cell death and differentiation, and synaptic plasticity. Given its different enzymatic activities, aberrant expression or activity of TG2 can contribute to tumorigenesis, including in peripheral and central nervous system tumors. Indeed, TG2 dysregulation has been reported in meningiomas, medulloblastomas, neuroblastomas, glioblastomas, and other adult-type diffuse gliomas. The aim of this review is to provide an overview of the biological and functional relevance of TG2 in the pathogenesis of nervous system tumors, highlighting its involvement in survival, tumor inflammation, differentiation, and in the resistance to standard therapies.Keywords
Funding Information
- Contributo Liberale (IG 2021 26515)
- Fondazione Italiana per la Ricerca sul Cancro (IG 2021 26515)
This publication has 207 references indexed in Scilit:
- World Health Organization 2021 Classification of Central Nervous System Tumors and Implications for Therapy for Adult-Type GliomasJAMA Oncology, 2022
- An update on the molecular biology of glioblastoma, with clinical implications and progress in its treatmentCancer Communications, 2022
- Transglutaminase 2: Friend or foe? The discordant role in neurons and astrocytesJournal of Neuroscience Research, 2018
- Transglutaminase is a tumor cell and cancer stem cell survival factorMolecular Carcinogenesis, 2015
- Molecular subclassification of diffuse gliomas: Seeing order in the chaosGlia, 2011
- Revision of the International Neuroblastoma Pathology ClassificationCancer, 2003
- Identification of differentially expressed proteins in human glioblastoma cell lines and tumorsGlia, 2003
- The International Neuroblastoma Pathology Classification (the Shimada system)Cancer, 1999
- DIFFERENTIAL GROWTH OF N- AND S-TYPE HUMAN NEUROBLASTOMA CELLS XENOGRAFTED INTO SCID MICE. CORRELATION WITH APOPTOSISThe Journal of Pathology, 1996
- Phenotype-specific “tissue” transglutaminase regulation in human neuroblastoma cells in response to retinoic acid: Correlation with cell death by apoptosisInternational Journal of Cancer, 1992